Walleye Capital LLC Solid Biosciences Inc. Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$2.02 - $3.08 $48,930 - $74,606	-24,223 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$2.1 - $3.42 $34,458 - $56,118	-16,409 Reduced 40.38%	24,223 $71,000
Q1 2020 May 15, 2020	SELL	$2.31 - $4.43 $30,880 - $59,220	-13,368 Reduced 24.76%	40,632 $97,000
Q4 2019 Feb 14, 2020	BUY	$2.82 - $12.9 $152,280 - $696,600	54,000 New	54,000 $240,000
Q3 2019 Nov 14, 2019	SELL	$4.33 - $11.64 $158,239 - $425,383	-36,545 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$4.6 - $10.13 $168,107 - $370,200	36,545 New	36,545 $210,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $40.5M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.